Literature DB >> 3618809

Effects of L-thyroxine in rats with chronic heart failure after myocardial infarction.

R Gay, T A Gustafson, S Goldman, E Morkin.   

Abstract

The effects of thyroid hormone on left ventricular (LV) function and myosin isoenzyme distribution were evaluated in rats 3 wk after myocardial infarction. When compared with normal rats, animals selected for study had moderately severe LV dysfunction as judged by decreased aortic and LV systolic pressures and a 34% decrease in LV maximum rate of pressure development (dP/dt). Average LV end-diastolic pressure was increased to 26 +/- 1 mmHg from 5 +/- 1 mmHg. The infarcted rats were divided into saline-treated control (n = 10) and treatment (n = 13) groups. The latter group received thyroxine (T4, 1.5 micrograms/100 g body wt) immediately after the first determination of pressures and at 24 and 48 h. At 72 h, aortic and LV pressures and myosin isoenzyme composition were measured. In the thyroxine-treated group LV end-diastolic pressure decreased from 27 +/- 2 to 18 +/- 2 mmHg, and LV dP/dt increased from 5,627 +/- 249 to 6,064 +/- 355 mmHg/s. Heart rate and aortic pressure did not change. After saline injections, LV end-diastolic pressure remained elevated, and the other hemodynamic parameters were unchanged. Determination of ventricular myosin isoenzyme composition in the saline-treated group revealed an increase in the V3 myosin isoform and a decrease in the V1 isoform as compared with the normal values. This pattern was not altered by T4 treatment. A separate group (n = 7) of rats was treated with a 10 times larger dose of thyroxine (15 micrograms/100 g body wt) for the same period of time. In this group, there was neither hemodynamic improvement nor changes in myosin isoenzyme distribution.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3618809     DOI: 10.1152/ajpheart.1987.253.2.H341

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and alpha-myosin heavy chain in rat hearts.

Authors:  K C Chang; V M Figueredo; J H Schreur; K Kariya; M W Weiner; P C Simpson; S A Camacho
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

2.  Thyroid hormone treatment to mend a broken heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  J Clin Endocrinol Metab       Date:  2008-04       Impact factor: 5.958

3.  Effect of triiodothyronine administration in experimental myocardial injury.

Authors:  R B Hsu; T S Huang; Y S Chen; S H Chu
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

4.  Thyroid hormone modulates membrane currents in guinea-pig ventricular myocytes.

Authors:  I Rubinstein; O Binah
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

5.  Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats.

Authors:  Yue-Feng Chen; Satoru Kobayashi; Jinghai Chen; Rebecca A Redetzke; Suleman Said; Qiangrong Liang; A Martin Gerdes
Journal:  J Mol Cell Cardiol       Date:  2007-10-26       Impact factor: 5.000

Review 6.  Rebuilding the post-infarcted myocardium by activating 'physiologic' hypertrophic signaling pathways: the thyroid hormone paradigm.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2008-09-05       Impact factor: 4.214

7.  Effects of chronic heart failure on the responsiveness to angiotensin I and to angiotensin converting enzyme inhibition with cilazapril in rats.

Authors:  J P Clozel
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

8.  Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats.

Authors:  Yue-Feng Chen; Nathan Y Weltman; Xiang Li; Steven Youmans; David Krause; Anthony Martin Gerdes
Journal:  J Transl Med       Date:  2013-02-14       Impact factor: 5.531

9.  In vitro and in vivo study on prevention of myocardial ischemic injury by taurine.

Authors:  Fengyun Ren; Xing Liu; Xiaoxue Liu; Yanli Cao; Lantao Liu; Xingjiang Li; Yingjun Wu; Shudi Du; Guozhong Tian; Jing Hu
Journal:  Ann Transl Med       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.